MedTrace Logo

Is Density Spectral Array Display Along With Bispectral Index Superior to the Display of Bispectral Index Alone

NCT07232160 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-11-18

No results posted yet for this study

Summary

A study to evaluate the use of density spectral array display in comparison with Bispectral index in a clinical setting.

Conditions

  • Awareness During General Anesthesia

Interventions

DEVICE

Depth of anesthesia monitoring using processed EEG

Comparison of processed EEG monitor (Bispectral index) with and without Density spectral array

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • The University of Queensland

    lead OTHER

Principal Investigators

  • Michael Boules, MB BCh · The University of Queensland

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2028-12-31
Completion
2029-12-31
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07232160 on ClinicalTrials.gov